Human Gingiva-Derived Mesenchymal Stem Cells Ameliorate Streptozoticin-induced T1DM in mice via Suppression of T effector cells and Up-regulating Treg Subsets

[1]  Xiaoshun He,et al.  Human Gingiva-Derived Mesenchymal Stem Cells Inhibit Xeno-Graft-versus-Host Disease via CD39–CD73–Adenosine and IDO Signals , 2017, Front. Immunol..

[2]  H. Yu,et al.  Indoleamine 2,3-Dioxygenase Is Not a Pivotal Regulator Responsible for Suppressing Allergic Airway Inflammation through Adipose-Derived Stem Cells , 2016, PloS one.

[3]  X. Wang,et al.  Intraperitoneal injection (IP), Intravenous injection (IV) or anal injection (AI)? Best way for mesenchymal stem cells transplantation for colitis , 2016, Scientific Reports.

[4]  Kalpesh R. Patil,et al.  Challenges and issues with streptozotocin-induced diabetes - A clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics. , 2016, Chemico-biological interactions.

[5]  S. Zheng,et al.  Progress and prospect of mesenchymal stem cell-based therapy in atherosclerosis. , 2016, American journal of translational research.

[6]  N. Chattopadhyay,et al.  Adipose-Derived Mesenchymal Stem Cells Prevent Systemic Bone Loss in Collagen-Induced Arthritis , 2015, The Journal of Immunology.

[7]  J. Gu,et al.  Human umbilical cord mesenchymal stem cells improve the immune-associated inflammatory and prothrombotic state in collagen type-Ⅱ-induced arthritic rats. , 2015, Molecular medicine reports.

[8]  C. Dong,et al.  Interleukin‐17A deficiency ameliorates streptozotocin‐induced diabetes , 2015, Immunology.

[9]  O. Korsgren,et al.  Preserved β-Cell Function in Type 1 Diabetes by Mesenchymal Stromal Cells , 2014, Diabetes.

[10]  J. Murphy,et al.  Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned? , 2014, Stem Cell Research & Therapy.

[11]  S. Zheng,et al.  Phenotypic and functional characteristic of a newly identified CD8+ Foxp3- CD103+ regulatory T cells. , 2014, Journal of molecular cell biology.

[12]  C. Verfaillie,et al.  Mesenchymal Stem Cells Migration Homing and Tracking , 2013, Stem cells international.

[13]  Seung U. Kim,et al.  CD39-mediated effect of human bone marrow-derived mesenchymal stem cells on the human Th17 cell function , 2013, Purinergic Signalling.

[14]  E. Vizi,et al.  CD39 and CD73 in immunity and inflammation. , 2013, Trends in molecular medicine.

[15]  J. Myśliwska,et al.  Loss of the balance between CD4(+)Foxp3(+) regulatory T cells and CD4(+)IL17A(+) Th17 cells in patients with type 1 diabetes. , 2013, Human immunology.

[16]  Y. Iwakura,et al.  Double deficiency in IL-17 and IFN-γ signalling significantly suppresses the development of diabetes in the NOD mouse , 2013, Diabetologia.

[17]  Zhiyong Guo,et al.  Adoptive transfer of human gingiva-derived mesenchymal stem cells ameliorates collagen-induced arthritis via suppression of Th1 and Th17 cells and enhancement of regulatory T cell differentiation. , 2013, Arthritis and rheumatism.

[18]  L. Ramalho,et al.  Dynamic changes of the Th17/Tc17 and regulatory T cell populations interfere in the experimental autoimmune diabetes pathogenesis. , 2013, Immunobiology.

[19]  Armand Keating,et al.  Mesenchymal stromal cells , 2006, Stem Cell Biology and Regenerative Medicine.

[20]  R. Mirmira,et al.  Targeting regulatory T cells in the treatment of type 1 diabetes mellitus. , 2012, Current molecular medicine.

[21]  M. Miloso,et al.  From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells , 2012, Stem Cell Research & Therapy.

[22]  Xuefeng Yu,et al.  Th17 cells in type 1 diabetes. , 2012, Cellular immunology.

[23]  Daniel J. Kuster,et al.  Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo , 2012, The Journal of experimental medicine.

[24]  R. Liblau,et al.  Tc17 CD8+ T Cells Potentiate Th1-Mediated Autoimmune Diabetes in a Mouse Model , 2012, The Journal of Immunology.

[25]  A. Le,et al.  Human Gingiva‐Derived Mesenchymal Stromal Cells Attenuate Contact Hypersensitivity via Prostaglandin E2‐Dependent Mechanisms , 2011, Stem cells.

[26]  E. Bonifacio,et al.  Expansion of Th17 Cells and Functional Defects in T Regulatory Cells Are Key Features of the Pancreatic Lymph Nodes in Patients With Type 1 Diabetes , 2011, Diabetes.

[27]  R. Schierl,et al.  Inhibition of T-Cell Proliferation by Murine Multipotent Mesenchymal Stromal Cells is Mediated by CD39 Expression and Adenosine Generation , 2011, Cell transplantation.

[28]  N. Eberhardt,et al.  Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models , 2011, Laboratory animals.

[29]  Y. Sotomaru,et al.  Neoplastic transformation by TERT in FGF-2-expanded human mesenchymal stem cells. , 2011, International journal of oncology.

[30]  Lingyun Sun,et al.  Allogeneic mesenchymal stem cells transplantation in patients with refractory RA , 2011, Clinical Rheumatology.

[31]  Q. Ouyang,et al.  Cutting Edge: Increased IL-17–Secreting T Cells in Children with New-Onset Type 1 Diabetes , 2010, The Journal of Immunology.

[32]  A. Xiang,et al.  Human Gingiva‐Derived Mesenchymal Stem Cells Elicit Polarization of M2 Macrophages and Enhance Cutaneous Wound Healing , 2010, Stem cells.

[33]  S. Segerer,et al.  Immune Cell–Derived C3 Is Required for Autoimmune Diabetes Induced by Multiple Low Doses of Streptozotocin , 2010, Diabetes.

[34]  Y. Belkaid,et al.  Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory Cells , 2010, The Journal of Immunology.

[35]  G. Tomar,et al.  Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine. , 2010, Biochemical and biophysical research communications.

[36]  F. Carrión,et al.  Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients , 2010, Lupus.

[37]  S. Shi,et al.  Mesenchymal Stem Cells Derived from Human Gingiva Are Capable of Immunomodulatory Functions and Ameliorate Inflammation-Related Tissue Destruction in Experimental Colitis1 , 2009, The Journal of Immunology.

[38]  M. V. von Herrath,et al.  Immunotherapy for the Prevention and Treatment of Type 1 Diabetes , 2009, Diabetes Care.

[39]  P. Lønning,et al.  Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. , 2009, Cancer research.

[40]  Philippe M. Campeau,et al.  Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner1 , 2009, The Journal of Immunology.

[41]  Manuel A. González,et al.  Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. , 2009, Arthritis and rheumatism.

[42]  A. Shapiro,et al.  Inhibition of Th17 Cells Regulates Autoimmune Diabetes in NOD Mice , 2009, Diabetes.

[43]  Yi-hong Wang,et al.  Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells , 2009, European journal of immunology.

[44]  Lingyun Sun,et al.  Transplantation of Human Bone Marrow Mesenchymal Stem Cell Ameliorates the Autoimmune Pathogenesis in MRL/lpr Mice , 2008, Cellular and Molecular Immunology.

[45]  A. Uccelli,et al.  Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.

[46]  S. Setty,et al.  IFN‐γ activation of mesenchymal stem cells for treatment and prevention of graft versus host disease , 2008, European journal of immunology.

[47]  J. Bluestone,et al.  Clinical application of regulatory T cells for treatment of type 1 diabetes and transplantation , 2008, European journal of immunology.

[48]  H. Lee,et al.  The Anti‐Inflammatory and Anti‐Angiogenic Role of Mesenchymal Stem Cells in Corneal Wound Healing Following Chemical Injury , 2008, Stem cells.

[49]  J. Ellis,et al.  Innocuous IFNγ induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production , 2008, The Journal of experimental medicine.

[50]  N. Rouas-Freiss,et al.  Human Leukocyte Antigen‐G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells , 2008, Stem cells.

[51]  Haisheng Peng,et al.  TGF-beta expression by allogeneic bone marrow stromal cells ameliorates diabetes in NOD mice through modulating the distribution of CD4+ T cell subsets. , 2008, Cellular immunology.

[52]  A. Nauta,et al.  Immunomodulatory properties of mesenchymal stromal cells. , 2007, Blood.

[53]  P. Rossini,et al.  Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. , 2007, Blood.

[54]  Y. Sher,et al.  Induction of a distinct CD8 Tnc17 subset by transforming growth factor‐β and interleukin‐6 , 2007, Journal of leukocyte biology.

[55]  Ulrich Göbel,et al.  bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 20, 2013. For personal use , 2004 .

[56]  Moustapha Hassan,et al.  Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells , 2004, The Lancet.

[57]  近藤 しおり.  Suppression of insulitis and diabetes in B cell-deficient mice treated with streptozocin : B cells are essential for the TCR clonotype spreading of islet-infiltrating T cells , 2004 .

[58]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[59]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[60]  B. Odermatt,et al.  A simple method for evaluating the rejection of grafted spleen cells by flow cytometry and tracing adoptively transferred cells by light microscopy. , 1997, Journal of immunological methods.

[61]  C Benoist,et al.  T helper cell subsets in insulin-dependent diabetes. , 1995, Science.

[62]  I. Cohen,et al.  Autoimmune Diabetes Induced by the β-cell Toxin STZ: Immunity to the 60-kDa Heat Shock Protein and to Insulin , 1994, Diabetes.